Key result
Previous cardiac operations in patients undergoing transapical aortic valve implantation were associated with similar hospital mortality (7.2% vs 7.9%; P=0.8) compared to a first cardiac procedure.
Why the study?
Does previous cardiac surgery impact hospital mortality and survival in patients undergoing transapical aortic valve implantation?
Population
566 patients undergoing transapical aortic valve implantation with the Sapien valve, from the Italian…
Comparison
Transapical aortic valve implantation in… vs Transapical aortic valve implantation as the…
Design
Cohort
Follow-up
mean 10.4 ± 7.9 months (range: 1-34)
Authors
Loading...
May support transapical TAVI in reoperative patients; leaves open randomized confirmation of mortality equivalence.
Cohort (n=566)
Yes
Does previous cardiac surgery impact hospital mortality and survival in patients undergoing transapical aortic valve implantation?
Absolute Event Rate: 7.2% vs 7.9%
p-value: p=0.8
Transapical TAVI is a viable and safe option for patients with previous cardiac surgery, yielding similar mortality and survival outcomes compared to patients undergoing their first cardiac procedure despite a higher baseline risk profile.
D’Onofrio et al. (2012) conducted a cohort in Patients undergoing transapical aortic valve implantation (TA-TAVI) (n=566). Previous cardiac operations with opening of the pericardium vs. First cardiac procedure was evaluated on Hospital mortality (p=0.8). Previous cardiac operations in patients undergoing transapical aortic valve implantation were associated with similar hospital mortality (7.2% vs 7.9%; P=0.8) compared to a first cardiac procedure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: